Medication info
Vaisib Tablet 10/20 Milligrams

Vaisib Tablet 10/20 Milligrams

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›20mg / 1 tablet
Manufacturer / importer
Celltrion Pharmaceutical Co., Ltd.
Appearance
White to off-white, bilaterally convex, rectangular tablet
Packaging
30 tablets/Alu-Alu
Approval status
Active

MFDS item code 201600853 · Approved 2016.02.15 · Insurance code 693902090

Summary

Main use
Treatment of primary and homozygous familial hypercholesterolemia and mixed hyperlipidemia
Who takes it
Adults
Adult dose
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medication. The dose of this medication should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This medication is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range of this medication is 10/10mg to 10/40mg once daily. The generally recommended initial dose is 10/20mg once daily. Patients who require less LDL cholesterol reduction may start at 10/10mg once daily. After starting treatment with this medication or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of at least 4 weeks. Due to the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medication should be used only in patients who have taken this medication at 10/80 mg for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily, administered in the evening. This medication is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration in patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, this medication is not recommended in patients with moderate or severe hepatic impairment (see 5. General Precautions, Patients with Abnormal Liver Function under Precautions for Use). Administration in patients with renal impairment and patients with concomitant chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer this medication at 10/20mg once daily in the evening. When administering higher doses of this medication to these patients, use caution and monitor them closely (see 5. General Precautions under Precautions for Use). Administration in older adults No dose adjustment is necessary when administered to older adults. Concomitant administration with other drugs (See 6. Interactions under Precautions for Use) This medication should be administered at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medication concomitantly with verapamil, diltiazem, or dronedarone should not exceed a dose of 10/10mg/day of this medication. Patients receiving this medication concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medication.

Ingredients

Manufacturer
Celltrion Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of primary and homozygous familial hypercholesterolemia and mixed hyperlipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerotic vascular disease due to hypercholesterolemia
  • dyslipidemia
  • diabetes
  • hypothyroidism
  • obstructive liver disease
  • chronic renal failure
View approved original text

This medication is used as an adjunct to diet in patients with primary hypercholesterolemia, particularly in those with heterozygous familial and non-familial hypercholesterolemia and mixed hyperlipidemia to lower total cholesterol, LDL cholesterol, ApoB protein, and triglycerides, and increase HDL cholesterol. Additionally, it is administered as an adjunct or alternative to other lipid-lowering therapies in patients with homozygous familial hypercholesterolemia for effective reduction of serum lipid levels. This drug is used in cases of insufficient response to dietary and other non-drug therapies, and patients at high risk of atherosclerotic vascular disease due to hypercholesterolemia require appropriate management. It is important to identify and treat secondary causes such as diabetes and hypothyroidism before using the medication. Lipid tests should include total cholesterol, LDL, HDL, and triglycerides, and special measurement methods may be required for patients with severe hypertriglyceridemia. Thus, this drug is used as a safe and effective management option for improving serum lipid levels in the treatment of hyperlipidemia.

How to take

Adult dose

Patients must follow a standard cholesterol-lowering diet before and during treatment with this medication. The dose of this medication should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This medication is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range of this medication is 10/10mg to 10/40mg once daily. The generally recommended initial dose is 10/20mg once daily. Patients who require less LDL cholesterol reduction may start at 10/10mg once daily. After starting treatment with this medication or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of at least 4 weeks. Due to the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medication should be used only in patients who have taken this medication at 10/80 mg for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily, administered in the evening. This medication is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration in patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, this medication is not recommended in patients with moderate or severe hepatic impairment (see 5. General Precautions, Patients with Abnormal Liver Function under Precautions for Use). Administration in patients with renal impairment and patients with concomitant chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer this medication at 10/20mg once daily in the evening. When administering higher doses of this medication to these patients, use caution and monitor them closely (see 5. General Precautions under Precautions for Use). Administration in older adults No dose adjustment is necessary when administered to older adults. Concomitant administration with other drugs (See 6. Interactions under Precautions for Use) This medication should be administered at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medication concomitantly with verapamil, diltiazem, or dronedarone should not exceed a dose of 10/10mg/day of this medication. Patients receiving this medication concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medication.

Precautions

This medication can cause serious muscle-related side effects such as myopathy and rhabdomyolysis. These side effects may manifest as muscle pain, muscle weakness, and significantly elevated creatine kinase levels in the blood. The risk is particularly greater with high doses, so dosage adjustment is crucial. This medication should not be administered to patients with poor liver function or active liver disease. Pregnant or breastfeeding women should not take this medication, and women planning to become pregnant must consult a doctor. Furthermore, caution is needed when combined with potent CYP3A4 inhibitors such as certain antifungals, antibiotics, and antivirals as the risk of muscle side effects may increase. There may also be interactions with other lipid-lowering agents, immunosuppressants, and certain anticoagulants, so patients must inform their healthcare provider of all medications they are currently taking. If symptoms of muscle pain or weakness occur during the use of this medication, patients should contact their doctor immediately, and regular blood tests should monitor muscle condition and liver function. Elderly patients or those with decreased kidney function should also use this medication with caution. Additionally, this medication may raise blood sugar levels in some patients, so those at risk for diabetes must manage their blood sugar carefully. Lastly, specific food intake such as grapefruit juice must be limited during the use of this medication, and patients should always inform their healthcare providers of this medication when starting new drugs.

Side effects

  • Myopathy
  • rhabdomyolysis
  • elevated creatine kinase
  • headache
  • diarrhea
  • influenza
  • upper respiratory infection
  • myalgia
  • limb pain
  • fatigue
Show 104 more
  • abdominal pain
  • viral infection
  • pharyngitis
  • sinusitis
  • arthralgia
  • low back pain
  • cough
  • anaphylaxis
  • urticaria
  • rash
  • angioedema
  • elevated liver aminotransferase levels
  • hepatitis
  • thrombocytopenia
  • nausea
  • pancreatitis
  • dizziness
  • sensory disturbances
  • depression
  • cholelithiasis
  • cholecystitis
  • skin-mucosal syndrome
  • toxic epidermal necrolysis
  • eosinophilia
  • drug reactions with systemic symptoms
  • erythema multiforme
  • liver damage
  • myasthenia
  • cataracts
  • constipation
  • dyspepsia
  • flatulence
  • nausea
  • eczema
  • pruritus
  • rash
  • muscle cramps
  • specific cranial nerve dysfunction
  • altered taste
  • ophthalmoplegia
  • facial paresis
  • tremors
  • peripheral neuropathy
  • peripheral nerve palsy
  • mental disorders
  • anxiety
  • sleep disorders
  • memory decline
  • forgetfulness
  • amnesia
  • memory impairment
  • confusion
  • interstitial lung disease
  • angioedema
  • lupus-like erythema
  • polymyalgia rheumatica
  • dermatomyositis
  • vasculitis
  • purpura
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibodies
  • increased erythrocyte sedimentation rate
  • arthritis
  • fever
  • chills
  • flushing
  • malaise
  • dyspnea
  • cholestatic jaundice
  • liver steatosis
  • cirrhosis
  • fulminant liver necrosis
  • liver cancer
  • liver failure
  • alopecia
  • various skin changes
  • lichenoid drug eruption
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • ocular muscle paralysis
  • anemia
  • elevated aminotransferases
  • increased ALP
  • elevated ɤ-GT
  • increased bilirubin levels
  • thyroid dysfunction
  • elevated serum creatine kinase
  • increased HbA1c
  • elevated fasting blood glucose levels
  • edema
  • thirst
  • facial swelling
  • syncope
  • insomnia
  • gastritis
  • atrophic gastritis
  • mucus stools
  • irritable bowel syndrome
  • sore throat
  • nocturia
  • hematuria
  • weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to avoid exposure to air and moisture, and it is safest to keep it at room temperature between 1 and 30 degrees Celsius. Storing it this way helps maintain the drug's efficacy and prevents degradation.

Appearance and packaging

Appearance

White to off-white, bilaterally convex, rectangular tablet

Package unit

30 tablets/Alu-Alu

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.